Viewing Study NCT06450964



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06450964
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-10
First Post: 2024-06-03

Brief Title: Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases
Sponsor: Anhui Medical University
Organization: Anhui Medical University

Study Overview

Official Title: Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to provide a reference for clinicians to conduct genetic counseling and carry out preimplantation genetic testing of mitochondrial patients The main questions it aims to answer are

The relationship between mitochondrial mutation load and clinical symptom
The symptomatic threshold of common mitochondrial DNA mutations
The distribution of mitochondrial mutation load in offspring and genetic rule of mitochondrial DNA mutation
The minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers Biological samples such as blood urine oral epithelial cells nails some granulosa cells trophoderm cells embryo culture fluid embryo biopsy fluid and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured The clinical symptoms and mutation load of the participants will be followed up once a year
Detailed Description: A total of 600 carriers of disease-causing mitochondrial DNA mutations will be selected as the research objects The basic information reproductive history clinical and genetic diagnosis and clinical symptoms of the carriers will be investigated by questionnaire Biological samples such as blood urine oral epithelial cells nails some granulosa cells trophoderm cells embryo culture fluid embryo biopsy fluid and embryo trophoblast cells of the participants will be collected and the mutation loads of them will be measured Placenta and umbilical cord blood samples of some fetuses will be collected after delivery and the mitochondrial DNA mutation heterogeneity level will be determined Multiple Logistic regression Sewell-Wright equation Kimura equation binomial distribution model and machine learning model will be used to establish a prediction model of the incidence probability of mitochondrial diseases and predict the onset threshold of common mitochondrial DNA mutations after standardizing The distribution model of mitochondrial mutation load in offspring will be established to predict the maternal genetic risk of mitochondrial DNA mutation A prediction model for egg retrieval will be established to estimate the minimum number of eggs taken by preimplantation genetic testing in mitochondrial mutation carriers Finally an online prediction platform for mitochondrial genetic disease genetic counseling will be established to provide standardized standards for mitochondrial disease genetic counseling and PGT

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None